Table 2.

Pathology diagnosis of ROI sites in the training and validation sets

DiagnosisNo. of sites in the training set (%)No. of sites in the validation set (%)
Normal53 (52.0)35 (61.4)
Mild dysplasia11 (10.8)5 (8.8)
Moderate dysplasia6 (5.9)5 (8.8)
Severe dysplasia/CIS12 (11.8)4 (7.0)
Invasive carcinoma20 (19.6)8 (14.0)
Total102 (100)57 (100)